This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The interventions were mass screening of the whole population aged 40 to 74 years; targeted screening of individuals living in deprived communities; targeted screening of individuals with a family history of premature cardiovascular disease; screening of individuals who either lived in deprived communities or had a family history of premature cardiovascular disease; and screening of individuals who both lived in deprived communities and had a family history of premature cardiovascular disease. A strategy of no screening was also considered.
Location/setting
UK/primary care.
Methods

Analytical approach:
The analysis was based on a single source of evidence and simulation models were run for two different populations, which were everyone aged 40 to 74 years who was at risk of cardiovascular disease, and men aged 40 to 54 years and women aged 40 to 64 years who were at risk of premature cardiovascular disease. A short time horizon was used, equivalent to the period of screening and follow-up for the screening results. The authors did not explicitly report the perspective adopted.
Effectiveness data:
All the clinical data were from the Scottish Health Survey, which was undertaken in 1998 and 2003. After excluding individuals with cardiovascular disease and those with missing data, the survey included 3,921 participants aged between 40 and 74 years, and 2,486 participants at risk of premature cardiovascular disease. The survey used multistage, stratified sampling to provide a representative sample of the Scottish population, and included face-to-face interviews and physical measurements. The risk factors for cardiovascular disease were the key endpoints. High risk was defined as an ASSIGN risk score of 20 or more, based on age, sex, systolic blood pressure, cigarette consumption, family history, and socio-economic status.
Monetary benefit and utility valuations:
Not considered.
